Controversies in Lung Cancer Screening

Area of Science:

• Pulmonology
• Radiology
• Oncology

Background:

• Lung cancer remains a leading cause of cancer death with poor survival rates for advanced disease.
• Despite improved treatments, early detection through screening is crucial for improving patient outcomes.
• Extensive debate exists regarding the benefits and drawbacks of lung cancer screening programs.

Purpose of the Study:

• To review the evidence supporting lung cancer screening with low-dose CT (LDCT).
• To address key concerns and challenges associated with implementing lung cancer screening in clinical practice.
• To provide guidance for radiologists regarding the integration of LDCT screening.

Main Methods:

• Review of major lung cancer screening trials, including the National Lung Screening Trial (NLST) and International Early Lung Cancer Program.
• Analysis of potential issues such as imaging workflow, radiation exposure, and nodule management.
• Discussion of biases (overdiagnosis, lead-time, length-time) and emerging technologies.

Main Results:

• Major screening studies demonstrate a reduction in lung cancer-specific mortality with LDCT screening.
• Significant concerns remain regarding workflow efficiency, radiation dose, and the management of small pulmonary nodules.
• Potential biases like overdiagnosis and economic factors require careful consideration.

Conclusions:

• Lung cancer screening with LDCT is supported by evidence showing reduced mortality.
• Addressing practical challenges in radiology is essential for successful screening implementation.
• A balanced approach is needed to maximize benefits while mitigating risks and costs.